These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9466528)

  • 21. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.
    Hansen K; Cruz M; Link H
    J Infect Dis; 1990 Jun; 161(6):1194-202. PubMed ID: 2345300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of a 130-kD matrix metalloproteinase in cerebrospinal fluid from a patient with Lyme neuroborreliosis.
    Hu LT; Perides G; Tanner LM; Klempner MS
    Clin Infect Dis; 1997 Jun; 24(6):1276-7. PubMed ID: 9195108
    [No Abstract]   [Full Text] [Related]  

  • 23. [The value of serological examination in neuroborreliosis].
    Thordsen S; Madsen C; Rosendahl L
    Ugeskr Laeger; 1993 Mar; 155(9):628-30. PubMed ID: 8447030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurologic manifestations in children with Lyme disease.
    Bingham PM; Galetta SL; Athreya B; Sladky J
    Pediatrics; 1995 Dec; 96(6):1053-6. PubMed ID: 7491220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis.
    Issakainen J; Gnehm HE; Lucchini GM; Zbinden R
    Klin Padiatr; 1996; 208(3):106-9. PubMed ID: 8676596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lyme neuroborreliosis disguised as normal pressure hydrocephalus.
    Danek A; Uttner I; Yoursry T; Pfister HW
    Neurology; 1996 Jun; 46(6):1743-5. PubMed ID: 8649583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Validity of positive anti-Borrelia antibodies in the diagnosis of neuroborreliosis].
    García-Moncó JC
    Neurologia; 1992 Feb; 7(2):47-9. PubMed ID: 1610599
    [No Abstract]   [Full Text] [Related]  

  • 28. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 in tumor cell invasion.
    French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ
    Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802
    [No Abstract]   [Full Text] [Related]  

  • 30. [Positive anti-Borrelia antibodies in patients with clinical manifestations compatible with neuroborreliosis].
    Izquierdo G; Aguilar J; Barranquero A; Navarro G; Borobio MV; Angulo S; Domínguez I; Quesada MA
    Neurologia; 1992 Feb; 7(2):50-4. PubMed ID: 1610600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of aging, localization, glucocorticoids and isotretinoin on matrix metalloproteases 2 (MMP-2) and 9 (MMP-9) in suction blister fluids.
    Kylmäniemio M; Autio P; Oikarinen A
    Arch Dermatol Res; 1995; 287(5):434-8. PubMed ID: 7625852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
    Torii K; Iida K; Miyazaki Y; Saga S; Kondoh Y; Taniguchi H; Taki F; Takagi K; Matsuyama M; Suzuki R
    Am J Respir Crit Care Med; 1997 Jan; 155(1):43-6. PubMed ID: 9001287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic neuroborreliosis in Lyme disease].
    Logigian EL
    Ter Arkh; 1996; 68(5):41-4. PubMed ID: 9082597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures.
    Perides G; Tanner-Brown LM; Eskildsen MA; Klempner MS
    J Neurosci Res; 1999 Dec; 58(6):779-90. PubMed ID: 10583909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid findings in neurological manifestations of Lyme disease.
    Pohl P; Schmutzhard E; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):314-20. PubMed ID: 3591080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The most frequent neurologic manifestations of Lyme disease].
    Umićević P; Makević M; Savanović V
    Glas Srp Akad Nauka Med; 1993; (43):219-23. PubMed ID: 8262410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis.
    Baig S; Olsson T; Höjeberg B; Link H
    Neurology; 1991 Apr; 41(4):581-7. PubMed ID: 1707148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis.
    Dotevall L; Rosengren LE; Hagberg L
    Infection; 1996; 24(2):125-9. PubMed ID: 8740104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gelatinases in drug-induced toxic epidermal necrolysis.
    Paquet P; Nusgens BV; Piérard GE; Lapière CM
    Eur J Clin Invest; 1998 Jul; 28(7):528-32. PubMed ID: 9726031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.